Twitter

Posts Tagged ‘dana’


Dr. Julia Wong on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Julia Wong, of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer patient’s …

Read More...

Dr. Julia Wong on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Julia Wong, of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer patient’s …

Read More...

Dr. Julia Wong on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Julia Wong, of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer patient’s …

Read More...

Dr. Jay Harris on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Jay Harris, chair of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer pati…

Read More...

Dr. Jay Harris on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Jay Harris, chair of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer pati…

Read More...

Dr. Jay Harris on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Jay Harris, chair of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer pati…

Read More...

Dr. Jay Harris on breast cancer treatment | Dana-Farber Cancer Institute

In this video, Dr. Jay Harris, chair of the Department of Radiation Oncology at Dana-Farber, talks about how radiation therapy fits into a breast cancer pati…

Read More...

Neuroblastomas Vulnerable To Novel Class Of Drugs May Be Identified By Genetic Biomarker

An irregularity within many neuroblastoma cells may indicate whether a neuroblastoma tumor, a difficult-to-treat, early childhood cancer, is vulnerable to a new class of anti-cancer drugs known as BET bromodomain inhibitors, Dana-Farber/Children’s Hospital Cancer Center scientists reported at the annual meeting of the American Association for Cancer Research in Washington, April 6-10…

Read More...

New 2-Drug Combination Effective For Some Patients With Incurable Tumors And BRCA Mutations

A novel combination of two drugs has shown anti-cancer activity in patients who had incurable solid tumors and carried a germline mutation in their BRCA genes, Dana-Farber Cancer Institute researchers reported at the American Association for Cancer Research annual meeting in Washington, April 6-10…

Read More...

Potential Novel Type Of Therapy For Ovarian Cancer

A new antibody-guided drug has shown promising activity in a phase I trial involving ovarian cancer patients with platinum drug-resistant disease, researchers from Dana-Farber Cancer Institute reported at the annual meeting of the American Association for Cancer Research…

Read More...